Abeona Therapeutics (NASDAQ:ABEO) Upgraded to Hold at StockNews.com
Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Friday. A number of other research firms also recently issued reports on ABEO. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $18.00 price objective […]
Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Friday. A number of other research firms also recently issued reports on ABEO. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $18.00 price objective […]
